IDEAYA BIOSCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.45 USD | -7.08% |
|
-9.40% | +8.07% |
Chart calendar IDEAYA Biosciences, Inc.
99.oUJzP5wjeW9jxHjCV69CGf3ffK7plQwfd_nq8D2JxeY.lzUdDLFIACsqgALwGOsTXrPqEvG49j8mAMHap2zBoJLYJkBR8FJIWyq-LQ~e55d4e6440e928c23658596210fc6e1e
Upcoming events on IDEAYA Biosciences, Inc.
Past events on IDEAYA Biosciences, Inc.
| 2024-05-14 03:05 pm | RBC Capital Markets Global Healthcare Conference - Fireside Chat |
| 2024-05-07 06:00 am | Q1 2024 Earnings Release |
| 2024-04-16 12:00 pm | Stifel Virtual Targeted Oncology Days Conference |
| 2024-03-12 08:00 am | Jefferies Biotech on the Bay Summit |
| 2024-03-11 12:40 pm | Leerink Partners Global Biopharma Conference |
| 2024-02-21 11:00 am | Citi Oncology Leadership Summit |
| 2024-02-20 06:00 am | Q4 2023 Earnings Release |
| 2024-02-14 01:20 pm | Oppenheimer Healthcare Life Sciences Conference |
| 2024-01-09 11:15 am | JPMorgan Healthcare Conference |
| 2023-12-05 12:00 pm | Barclays Lunchtime Fireside Chat Series |
| 2023-12-04 08:00 am | R&D Day |
| 2023-11-14 03:00 am | Jefferies London Healthcare Conference |
| 2023-11-07 06:00 am | Q3 2023 Earnings Release |
| 2023-10-23 02:50 am | European Society of Medical Oncology Congress - Session No. 1081O |
| 2023-09-11 10:40 am | Morgan Stanley Global Healthcare Conference |
| 2023-09-06 01:00 pm | Citi BioPharma Conference |
| 2023-08-10 06:00 am | Q2 2023 Earnings Release |
| 2023-08-08 03:00 pm | BTIG Virtual Biotechnology Conference |
| 2023-06-15 01:40 pm | Goldman Sachs Global Healthcare Conference |
| 2023-06-07 03:30 pm | Annual General Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 19,5 16,9 15.58% | 27,9 34,0 -17.74% | 50,9 53,9 -5.52% | 23,4 27,1 -13.63% | 12,1 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -48,5 -54,0 10.11% | -60,4 -64,3 6.02% | -132 -126 -5.07% | -199 |
|
EBIT Million USD | Released Forecast Spread | -44,3 -45,0 1.58% | -35,3 -36,5 3.21% | -50,3 -44,3 -13.56% | -62,5 -60,6 -3.12% | -134 -128 -5.23% | -201 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -42,0 -41,7 -0.66% | -34,5 -34,2 -0.81% | -49,8 -43,6 -14.09% | -58,7 -58,5 -0.22% | -113 -110 -2.34% | -172 |
|
Net income Million USD | Released Forecast Spread | -42,0 -42,8 1.85% | -34,5 -35,6 3.21% | -49,8 -43,5 -14.28% | -58,7 -59,0 0.52% | -113 -110 -2.6% | -176 |
|
EPS USD | Released Forecast Spread | -3,36 -2,16 -55.47% | -1,40 -1,47 4.49% | -1,41 -1,24 -13.61% | -1,42 -1,46 2.81% | -1,96 -1,94 -0.87% | -2,36 |
| Announcement Date | 24/03/20 | 23/03/21 | 15/03/22 | 07/03/23 | 20/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 11,4 6,71 69.31% | 5,85 6,59 -11.27% | 29,7 6,64 347.15% | 4,02 7,00 -42.54% | 7,88 5,38 46.6% | 3,54 4,40 -19.5% | 8,04 7,33 9.73% | 3,92 7,60 -48.41% | 0,00 4,89 - | 3,92 | 4,10 | 4,10 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -13,8 -22,0 37.47% | -22,0 -28,0 21.47% | 1,23 -31,0 103.96% | -25,9 -30,0 13.71% | -25,7 -32,0 19.72% | -38,6 | -51,7 | -54,1 | -56,7 | |||||
|
EBIT Million USD | Released Forecast Spread | -14,2 -16,5 13.69% | -22,5 -19,9 -13.25% | 0,66 -24,4 102.71% | -26,4 -24,1 -9.7% | -26,3 -27,4 4.07% | -32,7 -31,6 -3.64% | -33,5 -30,4 -10.37% | -41,9 -35,2 -19.13% | -51,0 -41,5 -22.86% | -48,2 | -50,0 | -51,5 | ||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -14,0 -16,8 16.61% | -22,1 -20,4 -8.27% | 1,62 -24,2 106.67% | -24,2 -24,0 -0.88% | -23,6 -26,7 11.51% | -27,9 -30,9 9.63% | -27,4 -28,7 4.48% | -34,0 -31,3 -8.33% | -39,6 -39,2 -1.05% | -42,4 | -44,1 | -46,1 | ||
|
Net income Million USD | Released Forecast Spread | -14,0 -16,2 13.29% | -22,1 -20,0 -10.19% | 1,62 -24,3 106.64% | -24,2 -24,0 -0.69% | -23,6 -26,4 10.47% | -27,9 -30,7 9.11% | -27,4 -29,5 7.03% | -34,0 -31,3 -8.4% | -39,6 -39,3 -0.81% | -42,8 | -44,7 | -47,0 | ||
|
EPS USD | Released Forecast Spread | -0,36 -0,41 12.39% | -0,57 -0,52 -10.66% | 0,04 -0,62 106.4% | -0,50 -0,56 11.1% | -0,49 -0,54 10% | -0,50 -0,56 10.6% | -0,46 -0,51 9.65% | -0,52 -0,48 -7.34% | -0,53 -0,52 -1.71% | -0,57 | -0,59 | -0,62 | -0,72 | -0,74 |
| Announcement Date | 10/05/22 | 15/08/22 | 08/11/22 | 07/03/23 | 09/05/23 | 10/08/23 | 07/11/23 | 20/02/24 | 07/05/24 | - | - | - | - | - |
| 2024-06-30 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
| 2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
Past sector events for IDEAYA Biosciences, Inc.
| 2024-05-21 | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
| 2024-05-21 | EVOTEC SE: Q1 2024 Earnings Release |
| 2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
| 2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | NUVATION BIO INC.: Q1 2024 Earnings Release |
| 2024-05-14 07:30 am | ABSCI CORPORATION: Q1 2024 Earnings Release |
| 2024-05-14 01:50 am | BELITE BIO, INC: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IDYA Stock
- Calendar IDEAYA Biosciences, Inc.
